KR20170103482A - Composition for prevention or treatment of oral disease comprising Glechoma hederacea extract - Google Patents

Composition for prevention or treatment of oral disease comprising Glechoma hederacea extract Download PDF

Info

Publication number
KR20170103482A
KR20170103482A KR1020160026454A KR20160026454A KR20170103482A KR 20170103482 A KR20170103482 A KR 20170103482A KR 1020160026454 A KR1020160026454 A KR 1020160026454A KR 20160026454 A KR20160026454 A KR 20160026454A KR 20170103482 A KR20170103482 A KR 20170103482A
Authority
KR
South Korea
Prior art keywords
oral
extract
streptococcus
disease
composition
Prior art date
Application number
KR1020160026454A
Other languages
Korean (ko)
Inventor
유정헌
조호성
이상화
Original Assignee
주식회사 엘지생활건강
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 주식회사 엘지생활건강 filed Critical 주식회사 엘지생활건강
Priority to KR1020160026454A priority Critical patent/KR20170103482A/en
Publication of KR20170103482A publication Critical patent/KR20170103482A/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/96Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
    • A61K8/97Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/105Plant extracts, their artificial duplicates or their derivatives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/53Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q11/00Preparations for care of the teeth, of the oral cavity or of dentures; Dentifrices, e.g. toothpastes; Mouth rinses
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23VINDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00Food compositions, function of food ingredients or processes for food or foodstuffs
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23VINDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2200/00Function of food ingredients
    • A23V2200/30Foods, ingredients or supplements having a functional effect on health
    • A23V2200/312Foods, ingredients or supplements having a functional effect on health having an effect on dental health

Abstract

The present invention relates to a composition comprising a Glechoma hederacea extract for preventing, alleviating, or treating oral diseases, wherein the composition is safe to a human body and has an excellent effect. The Glechoma hederacea extract is included in an amount of 0.001 to 10 wt% on the basis of the total weight of the composition, and the Glechoma hederacea extract is extracted by using at least one solvent selected from the group consisting of water, distilled water, methanol, ethanol, propanol, isopropanol, butanol, acetone, ether, benzene, chloroform, ethylacetate, methylene chloride, n-hexane, hydrochloric acid, acetic acid, formic acid, diethylether, and cyclohexane.

Description

[0001] The present invention relates to a composition for prevention or treatment of oral diseases,

TECHNICAL FIELD The present invention relates to a composition for oral administration, and more particularly, to a composition which is safe for human body and is excellent in prevention, improvement, or treatment of oral diseases such as dental caries, periodontal disease, bad breath,

In oral disease, dental caries and periodontal disease are known to cause various clinical symptoms such as pain, chewing dysfunction, periodontal tissue destruction, bad breath and saline, and are known to cause tooth loss. Cause factors are increasing.

It is a method to inhibit the growth of oral pathogens causing dental caries, periodontal disease, bad breath, and syringe while living in the dentine bacterial membrane. Various kinds of antimicrobial agents including antibiotics having bactericidal and bacteriostatic action for these bacteria , ≪ / RTI > size, and apical < RTI ID = 0.0 > infection. ≪ / RTI >

However, since antibiotics can cause systemic adverse effects on the body and cause the appearance of resistant bacteria and oral hyposensitization in oral cavity, it is difficult to use for a long period of time and can only be used as a therapeutic agent. In addition, the antimicrobial agents used in the oral cleanser include raw niacin, listerine, pyroxide, and chlorhexidine. Sangquinarine is not clear for the bacteria in the oral cavity, and its therapeutic effect in periodontal disease is further unclear Listerine is a major ingredient in alcohol. It has a temporary effect in the oral cavity, but it has a slight bacteriostatic action. However, it has a disadvantage that it can show a harmful effect on tissues during long-term use. Peroxide, which is added for the whitening effect, is poisonous to bacteria, but at the same time, toxic to human tissues, it is not only a safety problem, but also bacteria appear to be resistant to pyroxide in bacteria. Chlorhexidine is known to be one of the best known agents for the prevention and treatment of periodontal disease in addition to the prevention of periodontal disease. However, it is known that the stimulation of the tissue, pigmentation and degeneration of tissues, and especially the irritating taste, In addition, there is a disadvantage that it can not be used for a long period of time for the purpose of treatment or especially prevention, such as that there is a problem that it is caused by mutation,

Symptoms of dental caries, or dental hypersensitivity, are symptoms of toothache when eating fresh fruit or drinking cold water, which can lead to destruction of enamel and cement due to incorrect brushing, The dentinal tubules that were protected by the gums are exposed. In order to improve symptoms of such acne, a toothpaste for preventing acne has been developed and the dentinal tubules exposed by the dentistry are treated with a resin. However, a conventional toothpaste using a conventional ivory tubular sealing effect contains a fine powder of an effective ingredient to seal the ivory tubule. In general, the toothpaste is diluted in the process of brushing, and is washed away most of the time in the course of rinsing with water There is a problem in that the customs pipe is not sealed and exposed again.

Accordingly, the present inventors have conducted studies to derive an ingredient which is not harmful to the human body and which is harmless to human body, and is excellent in prevention and improvement of oral diseases such as dental caries, periodontal disease, bad breath,

Accordingly, the present invention aims at solving the above problems and providing such a useful use of a new active ingredient, that is, an active ingredient, which is less harmful to the human body and can inhibit the growth of bacteria in the oral cavity.

In other words, a problem to be solved by the present invention is to provide a composition comprising the active ingredient having excellent efficacy as an active ingredient, particularly a composition for oral care for preventing or improving dental caries, periodontal disease, or bad breath.

The present invention provides a composition for treatment or improvement of oral diseases using a naturally occurring ingredient that is safe and safe to use in the body.

The present invention provides a composition for oral cavity, which can relieve symptoms of acne by forming a coating film on the surface of a damaged tooth using a natural material.

In order to solve the above problems, the present invention provides an oral composition derived from a natural substance. Specifically, in one embodiment of the present invention, an oral composition comprising Glechoma hederacea as an active ingredient is provided.

In other words, the present invention provides a novel composition for oral care compositions, particularly oral compositions for preventing, ameliorating or treating various oral diseases.

The inventors of the present invention have conducted studies for development of an oral composition capable of exhibiting effects on the treatment, prevention and amelioration of diseases in the oral cavity by harmless to the human body. In particular, in the case of oral compositions containing Yeast extract, Effect and a tooth surface coating effect, thereby completing the present invention. Through the continuous research process of the inventors of the present invention, it was possible to first identify the therapeutic effect or preventive effect of oral extract of the present invention on oral diseases.

The method of using the soft gelatin capsule is not particularly limited, and may be powdered after drying and may be contained in the composition for oral use, preferably as an extract, in the oral composition.

As used herein, the term "extract" means an extract obtained by extracting a yeast extract, a diluted solution or a concentrate of the extract, a dried product obtained by drying the extract, a controlled preparation or a purified product of the extract, Extracts themselves and extracts of all formulations which can be formed using extracts.

The yeast extract of the present invention can be extracted from various organs of natural, hybrid, or variant plants at the beginning of the tillering and can be extracted from various organs such as seeds, roots, upper parts, stems, leaves, flowers, , Can be extracted from the plant tissue culture as well as from the bark of the fruit.

The above-mentioned yeast extract of the present invention can be preferably used as the above-ground portion.

In the yeast extract of the present invention, the method for extracting the yeast extract is not particularly limited and may be carried out according to a method commonly used in the art. Examples of the extraction method include hydrothermal extraction method, ultrasonic extraction method, filtration method, and reflux extraction method. These methods may be carried out singly or in combination of two or more methods, preferably using a hot water extraction method .

In the present invention, the kind of the extraction solvent used for extracting the soft gel is not particularly limited, and any solvent known in the art can be used. Nonlimiting examples of the extraction solvent include water, distilled water, methanol, ethanol, propanol, isopropanol, butanol, acetone, ether, benzene, chloroform, ethyl acetate, methylene chloride, n-hexane, hydrochloric acid, And cyclohexane. In the case of using alcohol as a solvent, C 1 to C 4 alcohols (methanol, ethanol, propanol, butanol) can be preferably used. In the present invention, water, ethanol or a mixture thereof may be used as the extraction solvent for the yeast extract.

In the present invention, the composition may be for preventing, improving or treating oral diseases.

In the present invention, the oral diseases include, for example, but not limited to, oral malodor, which may be caused by oral microorganisms, periodontal diseases including dental caries, gingivitis and periodontitis, and oral mucosal ulcers. Concept.

In addition, the oral disease may include various oral diseases which may be caused by external physical stimulation as well as by oral microorganisms. For example, dental caries may be exposed due to tooth surface wear, Syphilis can also include symptoms.

As used herein, the term " treatment " in the present invention refers to an approach to obtaining beneficial or desired clinical results, which may or may not be able to detect beneficial or desired clinical results for the purposes of the present invention, Including, but not limited to, relieving symptoms, decreasing the severity of the disease, stabilizing (i.e., not becoming worse) conditions of the disease, delaying or slowing the progression of the disease, improving or temporarily alleviating and alleviating the disease state, But is not limited thereto. Thus, treatment refers to both therapeutic treatment and prophylactic measures, and those that need treatment include conditions that already have the disease, as well as conditions in which the disease is to be prevented. It may also refer to any action that may improve or improve the symptoms of oral diseases by administering the pharmaceutical composition of the present invention to a subject.

"Prevention" may refer to any act that inhibits or delays disease using the oral composition. The oral composition may be used in the form of a pharmaceutical composition, a food composition, or an oral care composition, but is not necessarily limited thereto.

As used herein, the term "improvement" means that the above symptom is reduced or relieved, and can be understood as a broad concept including mitigation, prevention, and treatment.

As used herein, the term "bad breath" may refer to symptoms of unpleasant odors in the mouth, including, but not limited to, volatile sulfur compounds, An unpleasant smell may be caused in the mouth.

As used herein, the term "dental caries" refers to dental caries in which tooth enamel is damaged by acid generated by degradation of sugar and starch by bacteria in the mouth, resulting in tooth decay. The caries can be caused by various causes, for example, a plaque, which is a bacteria film formed on the tooth surface. When food is consumed, food residue remains in the mouth. If the acid generated by the decomposition of sugar or starch remaining in the mouth by plaque bacteria attacks the enamel of the tooth surface, dental caries can occur.

As used herein, the term "periodontal disease" is an oral disease involving gingivitis and periodontitis, depending on its degree, including but not limited to attack of bacteria below the gum line of the sulcus, It may appear to damage adjacent tissue.

The term "oral mucosal ulcer ", as used herein, is also referred to as stomatitis, and includes, but is not limited to, oral mucosa (tongue, gums, lips, And the like).

The oral disease may be caused by bacteria, and the bacterium may be a bacterium such as Streptococcus sp., Porphyromonas sp.

The composition for oral use of the present invention is useful for the treatment or prophylaxis of diseases caused by or associated with the genus of Streptococcus or Porphyromonas and more particularly Streptococcus mutans, Streptococcus sanguis, Streptococcus mutans, sanguinis, Streptococcus salivarius subsp. thermophils, and Porphyromonas gingivalis are excellent antibacterial effects to prevent, improve or prevent oral diseases It can have an excellent effect on the treatment.

More preferably, the oral composition of the present invention may exhibit an antibacterial effect on Streptococcus mutans or Porphyromonas gingivalis bacteria.

According to another embodiment of the present invention, the yeast extract of the present invention is contained in a composition for preventing, ameliorating or treating symptoms of schizophrenia.

As used herein, the term "syringe" refers to all phenomena, including, but not limited to, sharp, transient, or persistent pain to external stimuli, independent of tooth decay or other pathological causes. The external stimulus usually refers to a temperature stimulus, which is often accompanied by a cold temperature stimulus, which may cause pain at a hot temperature. In addition to such temperature stimuli, pain may also be caused by irritation, such as drying of teeth, contact with foreign substances, or osmotic pressure through sweet or new foods. It may appear entirely on the entire tooth and may be confined to specific areas such as the maxilla or mandible, right or left, dentine hyperesthesia, caries, or dental inflammation.

The cause of this symptom is considered to be the exposure of the mouth of the ivory tubule.

When the enamel or cementum is destroyed and the entrance of the dentinal tubule is exposed to the outside, the stimulation is transmitted to the dimension by the cell protrusion, nerve and dentin liquid of the dentinal tubule, and the pain can be felt.

The inventors of the present invention have found that the extract of the present invention can react with calcium ions contained in the needle to form a coating film on the tooth surface and prevent the coating film from preventing exposure of the ivory tubule to prevent, Respectively.

The composition for preventing or treating oral diseases of the present invention can be directly applied to animals including humans. The animal is a biological group corresponding to a plant. It mainly consumes organic matter as nutrients, and has digestion or excretion and differentiation of the respiratory organs. Preferably, it may be a vertebrate, more preferably a mammal. Specifically, the mammal may be a human, a pig, a cow, or a goat. The composition for preventing or treating oral diseases may contain the extract of the present invention alone as an active ingredient and may further contain additional components such as a pharmaceutically acceptable or nutritionally acceptable carrier, An excipient, a diluent or a subcomponent.

More particularly, the composition for preventing or treating oral diseases may further comprise, in addition to the active ingredient, a nutritional agent, a vitamin, an electrolyte, a flavoring agent, a colorant, a thickening agent, a pectic acid and a salt thereof, an alginic acid and a salt thereof, , a pH adjusting agent, a stabilizer, a preservative, a glycerin, an alcohol, and a carbonating agent used in a carbonated drink. The carrier, excipient or diluent may be selected from lactose, dextrose, sucrose, sorbitol, mannitol, xylitol, erythritol, maltitol, starch, acicia gum, alginate, gelatin, calcium phosphate, calcium silicate, cellulose, methylcellulose, microcrystalline In the group consisting of celluloses, polyvinylpyrrolidone, water, methylhydroxybenzoate, propylhydroxybenzoate, talc, magnesium stearate and mineral oil, dextrin, calcium carbonate, propylene glycol, liquid paraffin, But the present invention is not limited thereto. Any conventional carrier, excipient or diluent may be used.

The composition for preventing or treating oral diseases may further comprise conventional fillers, extenders, binders, disintegrants, surfactants, anti-coagulants, lubricants, wetting agents, flavoring agents, emulsifiers or preservatives, Or parenteral administration can be used.

Particularly, solid preparations for oral administration include tablets, pills, powders, granules, capsules and the like. These solid preparations may contain at least one excipient such as starch, calcium carbonate, Sucrose, lactose, gelatin and the like. In addition to simple excipients, lubricants such as magnesium stearate and talc may also be used. Examples of liquid formulations for oral use include suspensions, solutions, emulsions, syrups and the like. In addition to water and liquid paraffin which are commonly used simple diluents, various excipients such as wetting agents, sweeteners, fragrances, preservatives and the like may be included .

Examples of the form for parenteral administration include toothpastes, mouthwashes, topical administration agents (creams, ointments, dressing solutions, sprays, and other coating agents). As an example of the formulations of the topical administration agent, a composition for preventing or treating an oral disease including an extract of Yeast Extract, which is an effective ingredient, may be impregnated with a carrier such as gauze made of natural fibers or synthetic fibers.

In the case of the cream or ointment, it may be suitable for direct application to periodontal disease, gingival disease, or cavities or their surroundings. In the case of the above-mentioned spray agent, it can be manufactured by a conventional spray agent manufacturing method, except that it contains an extract powder as an active ingredient, and it is packed in a compressed container or other spray container and sprayed on the oral disease site at various times, Prevention or treatment. In the case of the dressing solution, the dressing solution can be manufactured by a conventional dressing solution manufacturing method except that it contains the yeast extract as an active ingredient. The dressing solution can be used for dressing or oral dressing in an oral disease site, Can be prevented or treated.

In addition, the formulation of the composition for preventing or treating oral diseases according to the present invention may be in a desired form depending on the method of use, and may be formulated so as to provide rapid, sustained or delayed release of the active ingredient, The method can be adopted. Exemplary formulations include, but are not limited to, excipients, granules, lotions, liniments, rimonadense, powders, syrups, solutions, aerosols, EXTRACTS, elixirs, ointments, Suspensions, tablets, capsules, creams, pills, soft or hard gelatine capsules, and the like.

Furthermore, the compositions for the prevention or treatment of oral diseases of the present invention can be prepared by any of the known methods known in the art or by a method disclosed in Remington's Pharmaceutical Science (recent edition), Mack Publishing Company, Easton PA And the like.

The dosage of the composition for preventing or treating oral diseases according to the present invention can be suitably selected by those skilled in the art in consideration of the administration method, the age, sex and weight of the recipient, severity of the disease, and the like. For example, the composition for preventing or treating oral diseases according to the present invention may be administered at a dose of 0.0001 mg / kg to 1000 mg / kg, and more preferably 0.01 mg / kg to 100 mg / kg. The administration may be carried out once a day or divided into several times. The dose is not intended to limit the scope of the invention in any way.

In addition, the composition for preventing or treating oral diseases according to the present invention may further comprise a compound having a known oral disease-inhibiting activity or a plant extract in addition to the extract of the yeast extract, and the content thereof may be varied depending on the preparation method and the purpose of use .

In one embodiment of the present invention, there is provided a food composition for preventing or ameliorating an oral disease, which comprises an extract of a yeast extract as an active ingredient. Examples of the food composition of the present invention include foods, food additives, beverages or beverage additives.

The food composition containing the above extract as an active ingredient may further comprise suitable carriers, excipients and diluents conventionally used in the production thereof.

As used herein, the term " food " means a natural product or a processed product containing one or more nutrients. Preferably, it means that the food can be directly eaten through a certain degree of processing. It is intended to include food, food additives, health functional foods and beverages.

Examples of foods to which the yeast extract of the present invention can be added include various foods, beverages, gums, candies, tea, vitamin complexes, and functional foods. In addition, in the present invention, the food may contain special nutritional foods (eg, crude oil, infant formula, etc.), meat products, fish products, tofu, mackerel, noodles (eg, (Such as soy sauce, soybean paste, hot pepper paste, mixed sauce), sauces, confectionery (eg snacks), dairy products (eg fermented milk, cheese), other processed foods, kimchi, pickled foods But are not limited to, natural flavors (eg, ramen soup, etc.), vitamin complexes, alcoholic beverages, alcoholic beverages and other health supplement foods. The food, beverage or food additive may be prepared by a conventional production method.

In the present invention, the functional food refers to a food group which is imparted with added value to function and express the function of the food by using physical, biochemical, biotechnological techniques and the like, the regulation of the biological defense rhythm of the food composition, The functional food of the present invention is preferably a food which is processed so that the body control function for preventing or ameliorating the oral disease can be sufficiently expressed in the living body It means food. The functional food may include a food-acceptable food-aid additive, and may further comprise suitable carriers, excipients and diluents conventionally used in the production of functional foods.

In the present invention, beverage is a generic term for drinking or enjoying a taste, and is intended to include functional beverages. The beverage is not particularly limited as long as it contains the above extract as an active ingredient as an essential ingredient at an indicated ratio, and may contain various flavors or natural carbohydrates as an additional ingredient such as ordinary beverages . Examples of such natural carbohydrates include monosaccharides such as disaccharides such as glucose and fructose such as maltose, sucrose and the like and polysaccharides such as dextrins, cyclodextrins and the like, and Xylitol, sorbitol, and erythritol. Natural flavors (tau martin, stevia extract (e.g., rebaudioside A, glycyrrhizin, etc.) and synthetic flavors (saccharin, aspartame, etc.) can be advantageously used as flavors other than those described above The ratio of the natural carbohydrate is generally about 1 to 20 g, preferably 5 to 12 g, per 100 ml of the composition of the present invention. In addition, the composition of the present invention can be applied to natural fruit juice, fruit juice drink, May be further contained.

In addition to the above-mentioned composition, the composition of the present invention can be used as a flavoring agent such as various nutrients, vitamins, minerals (electrolytes), synthetic flavors and natural flavors, coloring agents and intermediates (cheese, chocolate etc.), pectic acid and its salts, Salts, organic acids, protective colloid thickeners, pH adjusting agents, stabilizers, preservatives, glycerin, alcohols, carbonating agents used in carbonated beverages and the like. These components can be used independently or in combination.

The functional beverage according to the present invention can be used to control the bio-defense rhythm of the beverage group or beverage composition to which the added value is imparted so that the function of the beverage acts on the specific purpose by physical, biochemical or biotechnological techniques, Means a beverage which has been designed so that the body control function related to restoration and the like is sufficiently expressed in the living body.

The functional beverage is not particularly limited to the other ingredients except that it contains the extract of the present invention as an essential ingredient in the indicated ratio, and may contain various flavors or natural carbohydrates as an additional ingredient such as ordinary beverages . Examples of such natural carbohydrates include monosaccharides such as disaccharides such as glucose and fructose such as maltose, sucrose and the like and polysaccharides such as dextrins, cyclodextrins and the like, and xylitol , Sorbitol, and erythritol. Natural flavors (tau martin, stevia extract (e.g., rebaudioside A, glycyrrhizin, etc.) and synthetic flavors (saccharin, aspartame, etc.) can be advantageously used as flavors other than those described above .

The present invention provides an oral hygiene composition for preventing or ameliorating an oral disease, which comprises an extract of Yeast Extract as an active ingredient. The oral care composition of the present invention includes all kinds and formulations that can be used for oral hygiene. Non-limiting examples of the oral hygiene composition include toothpaste, mouthwash, oral spray, oral ointment, gum, and the like.

When the oral care composition of the present invention is a dentifrice, it may further comprise an abrasive, a dipping agent, a moisturizing agent, a foaming agent, a sweetener, a whitening agent or a flavoring agent, Examples of the abrasive include aluminum hydroxide, silicic anhydride, aluminum silicate, calcium hydroxide dibasic hydroxide and anhydrous calcium carbonate, calcium carbonate, calcium pyrophosphate, insoluble sodium metaphosphate, magnesium phosphate, magnesium carbonate, calcium sulfate, Polymethyl methacrylate, and the like can be used alone or in combination. The content of the abrasive may be generally 20% by weight to 90% by weight based on the total composition, but is not limited by the content.

When the oral care composition is a paste-like composition, the viscous solution may contain at least one of polyvinyl alcohol, sodium polyacrylate, polyacrylic acid / polyacrylic acid, polyvinyl alcohol, polyacrylic acid / Maleic acid copolymer and synthetic polymer derivatives such as carboxyvinyl polymer, and inorganic-based binders such as silica and laponite may be used singly or in combination. The content of the viscous agent may be generally from 0.3% by weight to 5% by weight based on the total composition, but is not limited by the content.

In addition, the oral hygiene composition may further contain sorbitol, glycerin, ethylene glycol, propylene glycol, polyether glycol, polypropylene glycol or the like as a moisturizing agent in its preparation.

In addition, the oral hygiene composition may further include a fragrance or a sweetener. The sweetener may be sucrose, lactose, maltose, sorbitol, xylitol, sodium cyclamate, glycerin, sodium saccharin, stevioside, aspartame, and the flavoring may be peppermint, menthol, anethole, The sweetener or fragrance may be used alone or in combination of two or more thereof. The sweetener or flavoring agent may be selected from the group consisting of alginic acid, citric acid, citric acid, limonene, citronellol, alpha terpineol, salicylmethyl, cineol, linarol, ethyl linolol, vanillin, thymol, spearmint oil, Or may be used in combination.

In addition, the oral hygiene composition of the present invention may contain a surfactant or an additional effective ingredient, which is used as a foaming component, alone or in combination. The surfactant used as the foaming component may be any one selected from the group consisting of an anionic surfactant, a nonionic surfactant and a cationic surfactant.

In the case where the oral care composition of the present invention is a dentifrice, the dentifrice composition of the present invention can be manufactured by a conventional dentifrice manufacturing method, The preparation can be prepared by mixing the herbal extract with a solution and formulating it into a saline solution. Oral diseases can be prevented or treated by washing the mouth 2 to 10 times a day.

Further, when the oral care composition of the present invention is a tooth paste cream, it may further include a liquid containing water and a moisturizing agent, a gelling agent or a water-insoluble polish agent, a sweetener, a fragrance and the like.

In addition, when the oral care composition of the present invention is a mouthwash (cleaning agent), it may further comprise a toothpaste carrier, more specifically, a non-toxic alcohol.

The method for preparing a composition for treating or preventing an oral disease of the present invention can be produced according to a method conventionally prepared in the art for manufacturing the same.

In the present invention, the yeast extract may be 0.001 to 10% by weight, preferably 0.005 to 5% by weight based on the total weight of the composition, more preferably 0.008 to 1% % ≪ / RTI > If the extract is less than 0.001% by weight based on the total weight of the composition, it may not be effective for oral diseases. If the extract is used in an amount of more than 10% by weight,

The oral composition according to the present invention may further contain, as components other than the above extract of yeast extract, a wetting agent, an abrasive, a pharmacological agent, a sweetener, a pH adjuster, a preservative, a binder, a fragrance, have.

The wetting agent may be used alone or in combination of one or more selected from the group consisting of concentrated glycerin, glycerin, sorbitol aqueous solution, amorphous sorbitol aqueous solution, polyethylene glycols and propylene glycol. The amount of the wetting agent is 1 to 70% by weight based on the total weight of the oral composition.

The abrasive may be one selected from the group consisting of precipitated silica, silica gel, zirconium silicate, calcium monohydrogenphosphate, anhydrous calcium hydrogenphosphate, hydrated alumina, hard calcium carbonate, heavy calcium carbonate, calcium pyrophosphate, insoluble metaphosphate and aluminum silicate Etc. may be used. The amount of the abrasive to be used is generally 1 to 60% by weight based on the total weight of the oral composition. As a small amount of additives to be used, commonly used ingredients include sweeteners, pH adjusters, preservatives, coloring agents, and binders.

The active agent may be selected from the group consisting of sodium fluoride, sodium fluorophosphate, sodium fluoride, tin fluoride, chlorohexidine, allantoin chlorohydroxy aluminate, aminocaproic acid, zinc chloride, pyridoxine hydrochloride, tocopheryl acetate, Or more.

As the sweetening agent, saccharin, xylitol, erythritol, aspartame and the like can be used. The amount of the sweetener to be used is generally 0.05 to 2% by weight based on the total weight of the oral composition.

As the pH adjusting agent, sodium phosphate, disodium phosphate, citric acid, triethanolamine and the like can be used.

As the preservative, benzoic acid, methylparaben, propylparaben, sodium benzoate and the like can be used. As the fragrance, peppermint oil, spearmint oil, menthol and the like may be mixed and used. Other additives such as dextrinase may be used.

Carrageenan, xanthan gum, carboxymethylcellulose sodium, carboxyvinyl polymer, sodium alginate, and laponite may be used alone or in admixture of two or more.

As foaming agent, a copolymer of sodium lauryl sulfate, an anionic surfactant, polyoxyethylene polyoxypropylene (non-ionic surfactant), polyoxyethylene hydrogenated castor oil, polyoxyethylene sorbitan fatty acid ester and the like can be used .

Others may include residual water.

According to another embodiment of the present invention, there is provided an oral hygiene product comprising the composition. The composition for oral hygiene according to the present invention comprising the extract of Chrysanthemum morifolium as an active ingredient is generally a composition for oral hygiene which can be included in all products manufactured and marketed for oral health and there is no limitation on the oral hygiene product to be applied . For example, the oral care products include, but are not limited to, toothpastes, oral sprays, oral ointments, mouth patches, and mouthwashes. The oral care product of the present invention may be in the form of a liquid, a solid, a suspension, a gel, and an aerosol, but is not limited thereto.

The composition containing the yeast extract of the present invention provides preventive, ameliorative or therapeutic effects of oral diseases.

The present invention provides a composition for preventing, ameliorating or treating oral diseases derived from natural materials, which has few side effects and is safe for the human body and can inhibit the growth of bacteria in the oral cavity.

It is possible to provide a composition which shows excellent dental caries, periodontal disease, prevention or improvement of bad breath, and is free of toxicity and excellent in stability.

Prevention and treatment of dental caries, and the like.

Hereinafter, the present invention will be described in more detail with reference to the following examples. However, the embodiments according to the present invention can be modified into various other forms, and the scope of the present invention should not be construed as being limited to the embodiments described below. The embodiments of the present invention are provided by way of example to facilitate a specific understanding of the present invention.

<Preparation of Yeast Extract Extract>

The crude extract of the present invention was prepared by the following method.

The top part of the yeast was cut into pieces and immersed in a 95% ethanol solution and extracted at room temperature for 48 hours.

<Experiment 1. Antibacterial effect test>

The antimicrobial activity test was carried out using the paper disk method to determine whether the antimicrobial activity was inhibited by using Gram positive Streptococcus mutans strains and Gram negative strains, Poppyromonas genus varis, which are representative bacteria of periodontal disease and periodontal disease. The bacterium was cultivated in the optimal culture conditions shown in Table 1 below, and cultured for 4 to 6 hours in the optimum medium of each microorganism. The turbidity of the culture was measured by Macfarland turbidity No. 2. 0.5 (1.5 x 10 8 ), and 0.1 ml was evenly smoothed. In a sterilized paper disk (Whatman no. 5 paper, 8 mm diameter), Yeast extract was inoculated at a concentration of 10 mg / disc and absorbed and dried for 1 hour before use. The size (mm diameter) of the growth inhibition rings was measured after 24-48 hours of incubation at the optimum temperature of each of the above bacteria.

Strain Optimum condition Gram staining Strain name Temperature badge characteristics Gram (+) Streptococcus mutans 37 ℃ BHI Facultative anaerobic Gram (-) Porphyromonas gingivalis 37 ℃ TSA Hemin Menadione medium Anaerobic

The results are shown in the following table.

The antimicrobial activity of oral extracts from Oral Pathogens

Growth inhibition diameter (mm) S.mutans P. gingivalis No treatment - (No inhibition) - (No inhibition) Extract treatment 10.7 11.3

<Experiment 2. Inhibitory effect of gingival inflammation formation>

In order to compare the degree of inhibition of gingival inflammation formation, it is preferable to firstly dissolve sodium carboxymethylcellulose sodium, sodium laurylsulfate, glycerin, colloidal silicon dioxide, silica, sodium cocoyl sodium catecholate , Dodine, a sweetener, a fragrance, a coloring agent and the like were used to prepare a control toothpaste, and an experimental toothpaste containing 0.01 wt.

Subjects were divided into 10 groups according to their gender, from 30 to 50 years of age. The subjects were divided into groups of 120 subjects. Clinical studies on the therapeutic effect of gingival inflammation were performed.

The subjects were divided into two groups: experimental group and control group. After training, they were instructed to use three times a day before sleeping after 2 hours' After 6 months and 6 months, oral examinations were performed to check gingival index. The gingival index was measured by inserting a periodontal probe into the gingival sulcus and burning around each tooth without applying any force. After 30 seconds, the gingival index was measured. And the results were obtained.

score Contents 0 point No bleeding state 1 point Normal bleeding state 2 points Hemorrhage 3 points Triangle Bleeding 4 points Gingival hemorrhage

Gingival inflammation inhibitory effect

group
time
Control group Test group
0 weeks 1.05 1.03 1 week 1.56 1.05 1 month 2.12 1.09 3 months 2.60 1.15 6 months 3.01 1.13

<Experiment 3. Comparison of inhibition of silent phenomenon>

In order to compare the degree of suppression of the syringes, there can be mentioned, first, carboxymethylcellulose sodium, sodium laurylsulfate, glycerin, colloidal silicon dioxide, silicas, sodium cocoyl sulfate, sodium cocoate, Control dentifrice was made using Dodicin, a sweetener, a fragrance, a coloring agent and the like, and an experimental dentifrice containing 0.01 wt%

The degree of suppression of the syringes of the compositions prepared above was compared and measured. In other words, the study subjects were 40 volunteers who agreed to participate in this experiment. Among the applicants, 20 were male and 20 were female, and the ages ranged from 20 to 50 years. The study subjects were not informed about the contents of the toothpaste, and the total test period was 2 weeks.

After the temperature stimulus was applied, the test was performed by measuring the response of the patient. Prior to the test, the hypersensitive areas of the hypersensitive teeth of each volunteer were checked in advance, and cold water of about 5 ° C was dropped on the acupressure of the teeth and dropped on a syringe. After the evaluation, each composition was used three times a day for 2 weeks After 2 weeks, cold water of about 5 ° C was dropped into the eyedropper. After the stimulation, the patient's response rating criteria were set as follows (0 points: no discomfort, 1 point: slightly uncomfortable, 3 points: sick). Statistical analysis was done by paired student-t test.

The scores for the temperature stimulation after 2 weeks are shown in Table 5 below.

Degree of inhibition

group
time
Control group Experimental group
0 weeks 2.10 ± 0.14 2.11 ± 0.21 2 weeks 2.09 ± 0.05 1.60 0.11 p > 0.05 * p < 0.05

As can be seen in Table 5 above, the response to temperature stimulation was much less in the experimental group treated with the Yeast Extract. This shows that the inhibitory effect of siline was excellent in the group treated with the extract of Yeast extract, and the component contained in the extract of Yeast extract of the present invention met the calcium component contained in the saliva and formed a coating film on the tooth surface, It was able to alleviate the hypersensitivity symptoms.

<Experiment 4. Experiment of removing bad breath>

Sodium carboxymethylcellulose sodium, sodium lauryl sulfate, glycerin, colloidal silicon dioxide, silicas, sodium cocoyl iodate, sodium dodecyne and sweetener, which are commonly used to make toothpastes for comparison of the degree of halitosis. , A perfume, a coloring agent and the like were used to prepare a control toothpaste, and an experimental toothpaste containing 0.01 wt%

Fifty men and women without dental caries were selected and cross-over test was performed for the beverage. The commercially available garlic powder was dispersed in water, allowed to stand for 24 hours, and diluted so that the measured value of the halimeter was 700 ppb or more. The diluted solution was used as a source of bad breath. After 30 minutes of gagging with 15 ml of garlic diluted solution, the degree of halitosis was measured with a half-meter after one minute, and then groomed for 30 seconds to 1 minute using a control group and an experimental group of toothpaste. After 1, 5, and 30 minutes of rinsing, the degree of halitosis was measured with a halimeter meter to measure the persistence of halitosis suppression. The results are shown in the following table.

Bad breath removal effect

group
time
Control group Experimental group
1 minute 53.7% 94.2% 5 minutes 40.5% 86.8% 30 minutes 32.4% 74.9%

[meaning]

It was confirmed that the extract of the yeast extract showed the effect of preventing or improving dental caries, gum disease, and removing bad breath. In addition, the degree of irritation to the temperature stimulus was improved to give a mitigating effect of silane.

It is believed that the extract of the present invention of the present invention is a natural material which is contained in an oral composition to effectively maintain and improve oral health.

Claims (16)

An oral hygiene composition for preventing or ameliorating an oral disease, comprising an extract of Yeast Extract as an active ingredient. The method according to claim 1, wherein the crude extract is selected from the group consisting of water, distilled water, methanol, ethanol, propanol, isopropanol, butanol, acetone, ether, benzene, chloroform, ethyl acetate, methylene chloride, n-hexane, Wherein the composition is extracted with at least one solvent selected from the group consisting of ethyl ether and cyclohexane. The oral care composition according to claim 1, wherein the extract is extracted with water, ethanol, or a mixture thereof. [Claim 3] The oral care composition according to claim 1, wherein the extract is contained in an amount of 0.001 to 10% by weight based on the total weight of the oral care composition. The oral care composition according to claim 1, wherein the oral disease is at least one disease selected from the group consisting of halitosis, syringe, dental caries, periodontal disease, and oral mucosal ulcer. The oral care composition according to claim 5, wherein the oral disease is psoriasis. The oral care composition according to claim 5, wherein the periodontal disease is gingivitis and periodontitis. The oral care composition of claim 1, wherein the composition has an antibacterial effect in streptococcus or Porphyromonas . The method of claim 8, wherein the Streptococcus (streptococcus) in or wrapping as Pseudomonas (Porphyromonas) genus Streptococcus mutans (streptococcus mutans), Streptococcus sanggwi switch (streptococcus sanguis), Streptococcus sanggwi varnish (Streptococcus sanguinis), Streptococcus Salivarius species Thermophilus ( Streptococcus salivarius subsp. thermophils , and Porphyromonas &lt; RTI ID = 0.0 &gt; gingivalis , &lt; / RTI &gt; and the like. 10. The method of claim 9, wherein the Streptococcus (streptococcus) The genus Streptococcus is Tansu mu (streptococcus mutans),
Wherein the Porphyromonas genus is Porphyromonas gingivalis . &Lt; RTI ID = 0.0 &gt; 11. &lt; / RTI &gt;
[Claim 7] The oral care composition of claim 1, wherein the extract has a coating on the surface of the teeth to relieve or ameliorate symptoms. The oral care composition according to claim 1, wherein the oral care composition has one or more formulations selected from the group consisting of a toothpaste, a mouthwash, an oral spray, an oral ointment, a mouth patch, and a gum. A food composition for preventing or ameliorating an oral disease, which comprises an extract of a yeast extract as an active ingredient. 14. The food composition according to claim 13, wherein the oral disease is at least one disease selected from the group consisting of halitosis, rhinorrhea, dental caries, periodontal disease, and oral mucosal ulcer. A pharmaceutical composition for preventing, ameliorating or treating oral diseases, which comprises an extract of a yeast extract as an active ingredient. [Claim 16] The pharmaceutical composition according to claim 15, wherein the oral disease is at least one disease selected from the group consisting of halitosis, sialin, dental caries, periodontal disease, and oral mucosal ulcer.
KR1020160026454A 2016-03-04 2016-03-04 Composition for prevention or treatment of oral disease comprising Glechoma hederacea extract KR20170103482A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
KR1020160026454A KR20170103482A (en) 2016-03-04 2016-03-04 Composition for prevention or treatment of oral disease comprising Glechoma hederacea extract

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
KR1020160026454A KR20170103482A (en) 2016-03-04 2016-03-04 Composition for prevention or treatment of oral disease comprising Glechoma hederacea extract

Publications (1)

Publication Number Publication Date
KR20170103482A true KR20170103482A (en) 2017-09-13

Family

ID=59968033

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1020160026454A KR20170103482A (en) 2016-03-04 2016-03-04 Composition for prevention or treatment of oral disease comprising Glechoma hederacea extract

Country Status (1)

Country Link
KR (1) KR20170103482A (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN109646390A (en) * 2019-02-28 2019-04-19 扬州倍加洁日化有限公司 A kind of chewing gargle tablet and preparation method thereof containing profitable probliotics

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN109646390A (en) * 2019-02-28 2019-04-19 扬州倍加洁日化有限公司 A kind of chewing gargle tablet and preparation method thereof containing profitable probliotics
CN109646390B (en) * 2019-02-28 2021-08-06 扬州倍加洁日化有限公司 Chewable gargle tablet containing probiotics and preparation method thereof

Similar Documents

Publication Publication Date Title
KR102408893B1 (en) Composition for prevention or treatment of oral disease comprising Pueraria Extract
KR20170141053A (en) Composition for prevention or treatment of dental disease comprising an extract of Gardenia jasminoides
KR102562835B1 (en) Composition for prevention or treatment of oral disease comprising ROSAE LAEVIGATAE Extract
KR101881636B1 (en) Composition for prevention or treatment of oral disease comprising Pueraria Extract
KR20170141034A (en) Composition for prevention or treatment of dental disease comprising Panax ginseng extract
KR102415612B1 (en) Composition for prevention or treatment of oral disease comprising Melonis Pedicellus Extract
KR20170142740A (en) Composition for treating or preventing oral diseases comprising natural complex
KR20170103482A (en) Composition for prevention or treatment of oral disease comprising Glechoma hederacea extract
KR20170037230A (en) Oral composition comprising cassava extract
KR101818211B1 (en) Composition for prevention or treatment of oral disease comprising Arctill fructus Extract
KR102562830B1 (en) Composition for prevention or treatment of oral disease comprising Kochiae Fructus Extract
KR102562829B1 (en) Composition for prevention or treatment of oral disease comprising Alpinia officinarum Extract
KR102562831B1 (en) Composition for prevention or treatment of oral disease comprising Gleditsiae fructus Extract
KR102417082B1 (en) Composition for prevention or treatment of oral disease comprising Celosia argentea Extract
KR20170142975A (en) Composition for prevention or treatment of oral disease comprising Leonurus sibiricus extract
KR102541843B1 (en) Composition for prevention or treatment of oral disease comprising Arctiin
KR102548925B1 (en) Composition for prevention or treatment of oral disease comprising Scopoletin
KR102564564B1 (en) Composition for prevention or treatment of oral disease comprising 2-methoxycinnamaldehyde
KR102580941B1 (en) Composition for prevention or treatment of oral disease comprising Qucercetin 3-glucoside
KR102156884B1 (en) Composition for prevention or treatment of oral disease comprising Meliae toosendan fructus Extract
KR20170118984A (en) Composition for prevention or treatment of oral disease comprising Leonurus sibiricus extract
KR20170141057A (en) Composition for prevention or treatment of dental disease comprising an extract of Daphne genkwa
KR20170103458A (en) Composition for prevention or treatment of oral disease comprising Aconitum ciliare extract
KR20170103517A (en) Composition for prevention or treatment of oral disease comprising Prunus yedoensis Matsumura extract
KR20170120414A (en) Composition for prevention or treatment of oral disease comprising Esculetin